XML 25 R11.htm IDEA: XBRL DOCUMENT

Note 4 - Licensing Agreements	9 Months Ended
Dec. 29, 2024
Notes to Financial Statements
Licensing Agreements [Text Block]	Note 4 – Licensing Agreements The Company has entered into licensing agreements that provide for royalty payments based on a percentage of sales with certain minimum guaranteed amounts. These royalty amounts are accrued based upon historical sales rates adjusted for current sales trends by customers. Royalty expense is included in cost of products sold in the accompanying unaudited condensed consolidated statements of income and amounted to $1.7 million and $1.3 million for the three months ended December 29, 2024 and December 31, 2023, respectively, and amounted to $4.5 and $3.8 million for the nine months ended December 29, 2024 and December 31, 2023, respectively.

Note 4 - Licensing Agreements

9 Months Ended

Dec. 29, 2024

Note 4 – Licensing Agreements

The Company has entered into licensing agreements that provide for royalty payments based on a percentage of sales with certain minimum guaranteed amounts. These royalty amounts are accrued based upon historical sales rates adjusted for current sales trends by customers. Royalty expense is included in cost of products sold in the accompanying unaudited condensed consolidated statements of income and amounted to $1.7 million and $1.3 million for the three months ended December 29, 2024 and December 31, 2023, respectively, and amounted to $4.5 and $3.8 million for the nine months ended December 29, 2024 and December 31, 2023, respectively.